| DANH MỤC BÀI BÁO QUỐC TẾ THÁNG 03/2020 |
| STT |
TÊN BÀI BÁO |
LINK BÀI BÁO |
TÊN BÁO/TẠP CHÍ |
TÁC GIẢ |
NGÀY ĐĂNG |
| 1 |
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32170560 |
Frontiers of medicine |
Zou X1, Chen K1, Zou J1, Han P2, Hao J3, Han Z4. |
12/3/2020 |
| 2 |
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32169119 |
Military Medical Research |
Guo YR1, Cao QD2, Hong ZS3, Tan YY1, Chen SD1, Jin HJ1, Tan KS4, Wang DY5, Yan Y6,7 |
13/3/2020 |
| 3 |
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32167747 |
ACS chemical neuroscience |
Baig AM1, Khaleeq A1, Ali U2, Syeda H3. |
13/3/2020 |
| 4 |
The establishment of reference sequence for SARS-CoV-2 and variation analysis |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32167180 |
Journal of medical virology |
Wang C1,2,3, Liu Z1,2, Chen Z2, Huang X2, Xu M1,2, He T1,2, Zhang Z1,2,4. |
13/3/2020 |
| 5 |
Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32165386 |
Microbiology resource announcements |
Sah R#1, Rodriguez-Morales AJ#2,3, Jha R4, Chu DKW5, Gu H5, Peiris M5, Bastola A6, Lal BK7, Ojha HC7, Rabaan AA8, Zambrano LI9, Costello A10, Morita K11, Pandey BD6, Poon LLM |
12/3/2020 |
| 6 |
The cyanobacterial saxitoxin exacerbates neural cell death and brain malformations induced by Zika virus |
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008060 |
Plos Neglected tropical diseases |
Carolina da S. G. Pedrosa |
12/3/2020 |
| 7 |
Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32179150 |
International journal of antimicrobial agents |
Baron SA1, Devaux C2, Colson P1, Raoult D3, Rolain JM4. |
13/3/2020 |
| 8 |
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32178975 |
Clinica chimica acta; international journal of clinical chemistry |
Lippi G1, Plebani M2, Michael Henry B3. |
13/3/2020 |
| 9 |
Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32178593 |
Emerging microbes & infections |
Vankadari N1, Wilce JA1. |
19/3/2020 |
| 10 |
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32173110 |
Journal of critical care |
Cortegiani A1, Ingoglia G2, Ippolito M2, Giarratano A2, Einav S3. |
10/3/2020 |
| 11 |
Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32173576 |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |
Liu F1, Xu A1, Zhang Y2, Xuan W3, Yan T3, Pan K1, Yu W1, Zhang J4. |
13/3/2020 |
| 12 |
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32172228 |
Clinical chemistry and laboratory medicine |
Lippi G1, Simundic AM2, Plebani M3. |
16/3/2020 |
| 13 |
Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32191676 |
Acta bio-medica : Atenei Parmensis |
Baglivo M1, Baronio M2, Natalini G3, Beccari T4, Chiurazzi P5, Fulcheri E6, Petralia PP7, Michelini S8, Fiorentini G9, Miggiano GA10, Morresi A11, Tonini G12, Bertelli M13. |
19/3/2020 |
| 14 |
Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32191588 |
Radiology |
Li L1, Qin L1, Xu Z1, Yin Y1, Wang X1, Kong B1, Bai J1, Lu Y1, Fang Z1, Song Q1, Cao K1, Liu D1, Wang G1, Xu Q1, Fang X1, Zhang S1, Xia J1, Xia J1. |
19/3/2020 |
| 15 |
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32190890 |
American journal of clinical pathology |
Iwen PC1,2, Stiles KL2, Pentella MA3. |
19/3/2020 |
| 16 |
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32187464 |
The New England journal of Medicine |
Cao B1, Wang Y1, Wen D1, Liu W1, Wang J1, Fan G1, Ruan L1, Song B1, Cai Y1, Wei M1, Li X1, Xia J1, Chen N1, Xiang J1, Yu T1, Bai T1, Xie X1, Zhang L1, Li C1, Yuan Y1, Chen H1, Li H1, Huang H1, Tu S1, Gong F1, Liu Y1, Wei Y1, Dong C1, Zhou F1, Gu X1, Xu J1, |
19/3/2020 |
| 17 |
|
|
|
|
|
| 18 |
|
|
|
|
|
| 19 |
Eleven Faces of Coronavirus Disease 2019. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32196678 |
Allergy |
Dong X1, Cao YY2, Lu XX3, Zhang JJ1, Du H3, Yan YQ4, Akdis CA5, Gao YD1. |
20/3/2020 |
| 20 |
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32194981 |
Cell discovery |
Liu J#1, Cao R#2, Xu M#1,3, Wang X1, Zhang H1,3, Hu H1,3, Li Y1,3, Hu Z1, Zhong W2, Wang M1. |
18/3/2020 |
| 21 |
Public health measures to slow community spread of COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32193550 |
The Journal of infectious diseases |
Cowling BJ1, Aiello A2. |
20/3/2020 |
| 22 |
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32207377 |
Emerging microbes & infections |
Nie J1, Li Q1,2, Wu J1,3, Zhao C1, Hao H1, Liu H1, Zhang L1, Nie L1, Qin H1, Wang M1, Lu Q1, Li X1, Sun Q1, Liu J1, Fan C4, Huang W1, Xu M5, Wang Y1, |
25/3/2020 |
| 23 |
Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32205220 |
Clinical gastroenterology and hepatology |
Luo S1, Zhang X2, Xu H1. |
20/3/2020 |
| 24 |
Insights from nanomedicine into chloroquine efficacy against COVID-19. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32203437 |
Nature nanotechnology |
Hu TY1, Frieman M2, Wolfram J3,4,5,6. |
23/3/2020 |
| 25 |
Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32200634 |
Journal of proteome research |
Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y. |
24/3/2020 |
| 26 |
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32200654 |
American journal of respiratory and critical care medicine |
Chang1,2, Mo G1, Yuan X1, Tao Y1, Peng X1, Wang F1, Xie L1, Sharma L3, Dela Cruz CS4, Qin E1. |
23/3/2020 |
| 27 |
Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32204943 |
Vaccine |
Dayan GH1, Langevin E2, Gilbert PB3, Wu Y4, Moodie Z5, Forrat R6, Price B7, Frago C8, Bouckenooghe A9, Cortes M10, Noriega F11, DiazGranados CA12 |
20/3/2020 |
| 28 |
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV |
https://www.nature.com/articles/s41467-020-15562-9 |
Nature Communications volume |
Xiuyuan Ou, |
27/3/2020 |
| 29 |
Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19 |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32221983 |
Journal of medical virology |
Cheng H1, Wang Y1, Wang GQ1,2, |
27/3/2020 |
| 30 |
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220310 |
cell |
Zhang YZ1, Holmes EC2. |
26/3/2020 |
| 31 |
SARS-CoV-2: What do we know so far? |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220035 |
Acta physiologica (Oxford, England) |
Khedkar PH1, Patzak A1.
|
27/3/2020 |
| 32 |
Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32219429 |
JAMA |
Roback JD1, Guarner J2. |
273/2020 |
| 33 |
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). |
http://login.research4life.org/tacsgr1www_ncbi_nlm_nih_gov/pubmed/32220033 |
Journal of internal medicine |
Wu J1,2, Li W3, Shi X1, Chen Z2, Jiang B4, Liu J5, Wang D6, Liu C7, Meng Y8, Cui L2, Yu J1, Cao H1,9, Li L1. |
27/3/2020 |